表纸
市场调查报告书

基于细胞的分析和高内涵筛选市场:按应用预测(2021-2025)

Cell Based Assay & High Content Screening Markets. Market Forecasts by Application. With Executive and Consultant Guides and including Customized Forecasting and Analysis. 2021 to 2025

出版商 Howe Sound Research 商品编码 969252
出版日期 内容资讯 英文 250 Pages
商品交期: 最快1-2个工作天内
价格
基于细胞的分析和高内涵筛选市场:按应用预测(2021-2025) Cell Based Assay & High Content Screening Markets. Market Forecasts by Application. With Executive and Consultant Guides and including Customized Forecasting and Analysis. 2021 to 2025
出版日期: 2020年11月05日内容资讯: 英文 250 Pages
简介

基于细胞的测定在药物开发和科学研究中起著主导作用,但是随著对COVID-19治疗的竞争加速,基于细胞的测定和高含量筛选市场正在迅速增长,并且该市场将继续。预计增长。

本报告调查了全球基于细胞的测定和高内涵筛选市场,包括市场规模,增长和限制因素,技术发展,用户类型/产品类别/区域市场分析,竞争状况和关键因素。它提供诸如公司资料之类的信息。

目录

市场指南

  • 情况分析和COVID-19的影响
  • 高管和营销人员指南
  • 投资分析师和管理顾问指南

第1章市场介绍和定义

  • 什么是基于细胞的测定?
  • 临床试验失败
  • 市场定义
  • 调查方法
  • 美国医疗市场和药物研究支出:前景

第2章基于细胞的分析技术指南

  • 细胞培养
  • 细胞测定
  • 细胞存活率测定
  • 细胞增殖测定
  • 细胞毒性测定
  • 细胞老化测定
  • 细胞凋亡
  • 自噬
  • 坏死
  • 氧化应激
  • 2D和3D
  • 信号通路,GPCR
  • 免疫调节和抑制
  • 记者基因工程
  • CBA设计与开发
  • 基于细胞的测定法

第3章行业概述

  • 市场进入公司
    • 学术研究室
    • 合同研究机构
    • 基因组仪器供应商
    • 细胞系和试剂供应商
    • 制药公司
    • 审计机构
    • 认证机构

第4章市场趋势

  • 生长因子
    • 候选人成长
    • 免疫肿瘤学
    • 基因组暴雪
    • 技术融合
    • 保险作用
  • 抑制器
    • CBA发展挑战
    • 设备集成
    • 协议
  • 技术发展
    • 3D分析
    • 自动化
    • 软件
    • 一次电池
    • 信号传导和报告基因
    • 未来5年

第5章基于细胞的分析的最新进展

  • 最新动态:本节的重要性和用法
    • 这些发展的重要性
    • 如何使用本节
      • Axxam和FUJIFILM Cellular Dynamics宣布建立战略联盟
      • CuriBio收购了一家人工智能公司Dana Solutions
      • CRISPR筛选揭示了新的癌症治疗靶标
      • ERS □□Genomics向Axxam授予CRISPR-Cas9专利
      • 新的转录本混合测定法可促进化合物筛选
      • 确定高通量抗癌候选药物
      • 查尔斯河实验室收购Citoxlab
      • 反应生物学公司收购ProQinase GmbH等。

第6章主要公司简介

  • Abcam
  • Agilent
  • Aurora Instruments Ltd.
  • Axxam
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments
  • BioVision, Inc.
  • BMG Labtech
  • Cell Biolabs, Inc
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories
  • Cisbio Bioassays
  • Corning, Inc.
  • Cytovale
  • Enzo Life Sciences, Inc.
  • Eurofins DiscoverX Corporation
  • Evotec AG
  • Excellerate Bioscience
  • Fujifilm Cellular Dynamics International
  • Genedata
  • Hemogenix
  • Horizon Discovery
  • Invivogen
  • Leica Biosystems
  • Lonza Group Ltd.
  • Luminex Corp
  • Merck & Co., Inc
  • Miltenyi Biotec
  • Molecular Devices
  • Nanion
  • Ncardia
  • New England Biolabs, Inc.
  • Olympus
  • Origene Technologies
  • Perkin Elmer
  • Promega
  • Qiagen Gmbh
  • Reaction Biology
  • Recursion Pharma
  • Roche Diagnostics
  • Sartorius
  • Sartorius-ForteBio
  • Sartorius-IntelliCyt
  • Sony Biotechnology
  • SPT Labtech
  • Stemcells Technologies Canada Inc.
  • Tecan
  • Thermo Fisher Scientific Inc.
  • Vitro Biopharma

第7章全球市场规模

  • 全球市场概况(按国家)
  • 按用户概述的全球市场
  • 全球产品类别概述

第8章按用户类型划分的全球市场

  • 制药
  • 调查
  • 工业/化妆品

第9章按产品类别进行基于细胞的分析

  • 设备
  • 试剂
  • 服务
  • 软件

第10章附录

  • 年度FDA癌症药物批准
  • 从2010年到2016年开始临床试验
  • 国家药品研发份额
目录

Cell Based Assays are a mainstay of drug development and scientific research, but growth is now accelerating as the race for a COVID-19 cure gains speed. On top of this new technology is allowing Cell Based Assays to be used to measure any aspect of cell function. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

ABOUT THE LEAD AUTHOR

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell is a member of The American Association for Clinical Chemistry. Mr. Powell's education includes:

B.Sc. (Chemistry) University of BC

M.B.A. (Finance and Policy) University of BC

Market Research Seminar - Burke Institute

Finance for Senior Executives - Harvard Business School

Table of Contents

i. Market Guides

  • iA. Situation Analysis & COVID-19 Impact
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1 What are Cell Based Assays?
  • 1.2 Clinical Trial Failures
    • 1.2.1 Immuno-oncology Plays a Leading Role in Cell Based Assays
    • 1.2.2 Infectious Disease Will Play a Larger Role
  • 1.3 Market Definition
    • 1.3.1 Market Size
    • 1.3.2 Currency
    • 1.3.3 Years
  • 1.4 Methodology
    • 1.4.1 Authors
    • 1.4.2 Sources
  • 1.5 U.S. Medical Market and Pharmceutical Research Spending - Perspective
    • 1.5.1 U.S. Expenditures for Pharmaceutical Research

2. Cell Based Assays - Guide to Technology

  • 2.1 Cell Cultures
    • 2.1.1 Cell Lines
    • 2.1.2 Primary Cells
    • 2.1.3 Stem Cells
      • 2.1.3.1 iPSC's - The Special Case
  • 2.2 Cell Assays
  • 2.3 Cell Viability Assays
  • 2.3 Cell Proliferation Assays
  • 2.4 Cytotoxicity Assays
  • 2.5 Cell Senescence Assays
  • 2.6 Apoptosis
  • 2.7 Autophagy
  • 2.8 Necrosis
  • 2.9 Oxidative Stress
  • 2.10 2D vs. 3D
  • 2.11 Signalling Pathways, GPCR
  • 2.12 Immune Regulation & Inhibition
  • 2.13 Reporter Gene Technology
  • 2.14 CBA Design & Development
  • 2.15 Cell Based Assays - The Takeaway

3. Industry Overview

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Contract Research Organization
    • 3.1.3 Genomic Instrumentation Supplier
    • 3.1.5 Cell Line and Reagent Supplier
    • 3.1.6 Pharmaceutical Company
    • 3.1.7 Audit Body
    • 3.1.8 Certification Body

4. Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Candidate Growth
    • 4.1.2 Immuno-oncology
    • 4.1.3 Genomic Blizzard
    • 4.1.4 Technology Convergence
    • 4.1.5 The Insurance Effect
  • 4.2 Factors Limiting Growth
    • 4.2.1 CBA Development Challenges
    • 4.2.2 Instrument Integration
    • 4.2.3 Protocols
  • 4.3 Technology Development
    • 4.3.1 3D Assays
    • 4.3.2 Automation
    • 4.3.3 Software
    • 4.3.4 Primary Cells
    • 4.3.5 Signalling and Reporter Genes
    • 4.3.6 The Next Five Years

5. Cell Based Assays Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
      • Axxam and FUJIFILM Cellular Dynamics Announce Strategic Alliance
      • Cancer Genetics to Acquire Organoid Startup Stemonix
      • Curi Bio Acquires Artificial Intelligence Firm Dana Solutions
      • CRISPR Screens Uncover Novel Cancer Therapy Targets
      • ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam
      • New Transcriptomics Assay Facilitates Compound Screens
      • Carta Biosciences Betting on Gene Interaction Mapping
      • High-throughput Identifies cancer drug candidates
      • Velabs Therapeutics partners with Alytas Therapeutics to develop a novel immune-based therapy for obesity
      • InSphero platform selected to test Cyclerion's sGC stimulator technology
      • OcellO to provide in vitro research services to Merus
      • Charles River Laboratories to acquire Citoxlab
      • Reaction Biology Corporation Purchases ProQinase GmbH
      • Cisbio extends its assay portfolio for immuno-oncology drug discovery
      • STEMCELL Technologies Launches Next-Generation Culture System
      • Abcam Acquires Calico Biolabs
      • Evotec announces achievement in Celgene alliance utilizing IPSC screening
      • Fujifilm Cellular Dynamics Inc. launches iCELL Microglia
      • Cisbio and Excellerate Bioscience partner
      • Horizon Discovery extends CRISPR Screening Service to primary human T cells

6. Profiles of Key Cell Based Assay Companies

  • Abcam
  • Agilent
  • Aurora Instruments Ltd.
  • Axxam
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments
  • BioVision, Inc.
  • BMG Labtech
  • Cell Biolabs, Inc
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories
  • Cisbio Bioassays
  • Corning, Inc.
  • Cytovale
  • Enzo Life Sciences, Inc.
  • Eurofins DiscoverX Corporation
  • Evotec AG
  • Excellerate Bioscience
  • Fujifilm Cellular Dynamics International
  • Genedata
  • Hemogenix
  • Horizon Discovery
  • Invivogen
  • Leica Biosystems
  • Lonza Group Ltd.
  • Luminex Corp
  • Merck & Co., Inc
  • Miltenyi Biotec
  • Molecular Devices
  • Nanion
  • Ncardia
  • New England Biolabs, Inc.
  • Olympus
  • Origene Technologies
  • Perkin Elmer
  • Promega
  • Qiagen Gmbh
  • Reaction Biology
  • Recursion Pharma
  • Roche Diagnostics
  • Sartorius
  • Sartorius-ForteBio
  • Sartorius-IntelliCyt
  • Sony Biotechnology
  • SPT Labtech
  • Stemcells Technologies Canada Inc.
  • Tecan
  • Thermo Fisher Scientific Inc.
  • Vitro Biopharma

7. Global Market Size

  • 7.1 Global Market Overview by Country
    • 7.1.1 Table - Global Market by Country
    • 7.1.2 Chart - Global Market by Country
  • 7.2 Global Market by User - Overview
    • 7.2.1 Table - Global Market by User
    • 7.2.2 Chart - Global Market by User - Base/End Year Comparison
    • 7.2.3 Chart - Global Market by User - Base Year
    • 7.2.4 Chart - Global Market by User - End Year
    • 7.2.5 Chart - Global Market by User - Share by Year
  • 7.3 Global Market by Product Class - Overview
    • 7.3.1 Table - Global Market by Product Class
    • 7.3.2 Chart - Global Market by Product Class - Base/End Year Comparison
    • 7.3.3 Chart - Global Market by Product Class - Base Year
    • 7.3.4 Chart - Global Market by Product Class - End Year
    • 7.3.5 Chart - Global Market by Product Class - Share by Year

8. Global Market by User Type

  • 8.1 Pharma
    • 8.1.1 Table Pharma - by Country
    • 8.1.2 Chart - Pharma Growth
  • 8.2 Research
    • 8.2.1 Table Research - by Country
    • 8.2.2 Chart - Research Growth
  • 8.3 Industry/Cosmetic
    • 8.3.1 Table Industry/Cosmetic - by Country
    • 8.3.2 Chart - Industry/Cosmetic Growth

9. Cell Based Assay by Product Class

  • 9.1 Instrument
    • 9.1.1 Table Instrument - by Country
    • 9.1.2 Chart - Instrument Growth
  • 9.2 Reagent
    • 9.2.1 Table Reagent - by Country
    • 9.2.2 Chart - Reagent Growth
  • 9.3 Services
    • 9.3.1 Table Services - by Country
    • 9.3.2 Chart - Services Growth
  • 9.4 Software
    • 9.4.1 Table Software - by Country
    • 9.4.2 Chart - Software Growth

10. Appendices

  • 10.1 FDA Cancer Drug Approvals by Year
  • 10.2 Clinical Trials Started 2010 to 2016
  • 10.3 Share of Pharma R&D by Country

Table of Tables

  • Table 1 The Large Variety of Cell Lines
  • Table 2 Some Common Viability Assays
  • Table 3 Oxidative Stress Related Diseases
  • Table 4 Important Signalling Pathways
  • Table 5 Market Players by Type
  • Table 6 Five Factors Driving Growth
  • Table 7 Three Factors Limiting Growth
  • Table 8 - Global Market by Region
  • Table 9 Global Market by User
  • Table 10 Global Market by Product Class
  • Table 11 Pharma by Country
  • Table 12 Research by Country
  • Table 13 Industry/Cosmetic by Country
  • Table 14 Instrument by Country
  • Table 15 Reagent by Country
  • Table 16 Services by Country
  • Table 17 Software by Country

Table of Figures

  • Figure 1 Reasons for clinical Failure by Phase
  • Figure 2 Immunotherapy Clinical Trial Growth
  • Figure 3 Pharmaceutical Research Expenditures 2001 to 2017 ($Billion)
  • Figure 4 Oxidative Stress and Free Radical Toxicity
  • Figure 5 FDA Cancer Drug Approvals
  • Figure 6 Growth rates of Cell Based Assays by Product Class
  • Figure 7 Global Market Share Chart
  • Figure 8 Global Market by User - Base vs. End Year
  • Figure 9 Global Market by User Base Year
  • Figure 10 Global Market by User End Year
  • Figure 11 User Share by Year
  • Figure 12 Global Market by Product Class - Base vs. End Year
  • Figure 13 Global Market by Product Class Base Year
  • Figure 14 Global Market by Product Class End Year
  • Figure 15 Product Class Share by Year
  • Figure 16 Pharma Growth
  • Figure 17 Research Growth
  • Figure 18 Industry/Cosmetic Growth
  • Figure 19 Instrument Growth
  • Figure 20 Reagent Growth
  • Figure 21 Services Growth
  • Figure 22 Software Growth
  • Figure 23 FDA Cancer Drug Approvals by Year
  • Figure 24 Clinical Trials for Immunotherapy by Year
  • Figure 25 Share of Pharma R&D by Country